Log in

Relevant bibliographies by topics / Neuroacanthocytosi / Journal articles

To see the other types of publications on this topic, follow the link: Neuroacanthocytosi.

Journal articles on the topic 'Neuroacanthocytosi'

Author: Grafiati

Published: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Neuroacanthocytosi.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Saiz Garcia, H., L. Montes Reula, A. Portilla Fernandez, V. Pereira Sanchez, N. Olmo Lopez, E. Mancha Heredero, and A. S. Rosero Enriquez. "Neuroacanthocytosis syndromes and neuropsychiatry symptoms associated." European Psychiatry 41, S1 (April 2017): S702. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1246.

Full text

Abstract:

IntroductionNeuroacanthocytosis is an infrequent cause of both neurological and psychiatric manifestations, and acanthocytes, which are a special form of spiculated red blood cells. Clinically significant psychopathology, ranging from behavioural disturbance to frank psychiatric illness, has been reported to occur in up to 60% of ChAc patients.MethodsA review was conducted aiming to clarify the physiopathology of this illness and its clinical features in order to distinguish neuroacanthocytosis from other neurological or psychiatric diseases. The literature search was conducted in PubMed data reviewing articles dating between 2010 and 2016.Results– Neuroacanthocytosis autosomal recessive disorder associated with mutations or deletions in the VPS13A gene on chromosome 9q, which codes for the membrane protein chorein. Chorein is strongly expressed in the brain. Chorein loss particularly affects the basal ganglia, especially the caudate nucleus and putamen;– Dysexecutive syndromes, OCD, depression and possibly psychosis, which may precede the frank motor and cognitive impairment;– The most recently developed treatment for neuroacanthocytoses is the use of deep-brain stimulation (DBS), with stimulation of the globus pallidus internus.ConclusionsWhile conducting a neurological exam, secondary causes of psychosis have to be included in the differential diagnosis. It is important to notice the possible confusion between tardive dyskinesia and a primary movement disorder. It should be necessary to investigate all de novo movement disorders in psychotic patients in order to eliminate etiologies other than iatrogenic ones.Disclosure of interestThe authors have not supplied their declaration of competing interest.

APA, Harvard, Vancouver, ISO, and other styles

2

Shah, J. R., D. P. Patkar, and R. N. Kamat. "A Case of McLeod Phenotype of Neuroacanthocytosis Brain MR Features and Literature Review." Neuroradiology Journal 26, no. 1 (February 2013): 21–26. http://dx.doi.org/10.1177/197140091302600103.

Full text

Abstract:

Huntington's disease and neuroacanthocytosis may present similar clinical and MRI features. It is important to differentiate these findings since treatment and prognosis vary vastly between them. The aim of this article is to familiarize radiologists with the differentiating features of Huntington's disease and various diseases comprising neuroacanthocytosis. A 40-year-old Indian man with extrapyramidal symptoms was referred for MRI. The clinical diagnosis was Huntington's disease, but there were a few atypical clinical features such as a history of biting the tongue, tics, marked hyporeflexia and lower limb muscle wasting. MR showed atrophy of the caudate nucleus and putamen with iron deposition in the basal ganglia, which can be seen in Huntington's disease and in neuroacanthocytosis. An increased blood acanthocyte level was subsequently confirmed. Further work-up revealed increased serum creatine phosphokinase levels, normal serum lipoprotein levels and depressed K cell antigen activity on serological studies, confirming the diagnosis of McLeod syndrome. McLeod syndrome is one of the distinct phenotypes of neuroacanthocytosis. Neuroacanthocytosis is a group of disorders with increased serum acanthocyte counts and neurological involvement. Various causes of neuroacanthocytosis are discussed. It is important to consider the possibility of neuroacanthocytosis when features typical of Huntington's disease are encountered on imaging.

APA, Harvard, Vancouver, ISO, and other styles

3

Zeman, Adam, and Geoff Shenton. "Neuroacanthocytosis." Practical Neurology 4, no. 5 (October 2004): 298–301. http://dx.doi.org/10.1111/j.1474-7766.2004.00249.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

ROBINSON, DAVID, MICHAEL SMITH, and R. REDDY. "Neuroacanthocytosis." American Journal of Psychiatry 161, no. 9 (September 2004): 1716. http://dx.doi.org/10.1176/appi.ajp.161.9.1716.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Danek, Adrian, and Ruth H. Walker. "Neuroacanthocytosis." Current Opinion in Neurology 18, no. 4 (August 2005): 386–92. http://dx.doi.org/10.1097/01.wco.0000173464.01888.e9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Chowdhury, Fateha, Rani Saward, and Wendy N. Erber. "Neuroacanthocytosis." British Journal of Haematology 131, no. 3 (November 2005): 285. http://dx.doi.org/10.1111/j.1365-2141.2005.05644.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Danek, Adrian, Benedikt Bader, and Ruth H. Walker. "Neuroacanthocytosis." Clinics 63, no. 1 (2008): 135. http://dx.doi.org/10.1590/s1807-59322008000100021.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Jung, Hans H., Adrian Danek, and Ruth H. Walker. "Neuroacanthocytosis Syndromes." Orphanet Journal of Rare Diseases 6, no. 1 (2011): 68. http://dx.doi.org/10.1186/1750-1172-6-68.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Bohlega, S., W. Riley, J. Powe, R. Baynton, and G. Roberts. "Neuroacanthocytosis and aprebetalipoproteinemia." Neurology 50, no. 6 (June 1, 1998): 1912–14. http://dx.doi.org/10.1212/wnl.50.6.1912.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Peppard, R. F., C. S. Lu, Nai-Shin Chu, P. Teal, W. R. W. Martin, and D. B. Calne. "Parkinsonism with Neuroacanthocytosis." Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques 17, no. 3 (August 1990): 298–301. http://dx.doi.org/10.1017/s0317167100030602.

Full text

Abstract:

ABSTRACT:Two patients with neuroacanthocytosis are described. One presented with parkinsonism and the other resembled diurnal dystonia of the Segawa type. Both patients responded well to dopaminomimetic therapy. A PET scan with fluorodopa revealed a nigrostriatal deficit in the first patient.

APA, Harvard, Vancouver, ISO, and other styles

11

Boughammoura-Bouatay, A., M. Karmani, S. Chebel, and M. Frih-Ayed. "Neuroacanthocytose et épilepsie." La Revue de Médecine Interne 26, no. 9 (September 2005): 756–58. http://dx.doi.org/10.1016/j.revmed.2005.04.032.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Rinne, J. O., S. E. Daniel, F. Scaravilli, A. E. Harding, and C. D. Marsden. "Nigral degeneration in neuroacanthocytosis." Neurology 44, no. 9 (September 1, 1994): 1629. http://dx.doi.org/10.1212/wnl.44.9.1629.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Walker, Ruth H. "Management of Neuroacanthocytosis Syndromes." Tremor and Other Hyperkinetic Movements 5 (October 19, 2015): 346. http://dx.doi.org/10.5334/tohm.274.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Balhara, Yatan Pal Singh, Sunny T. Varghese, and Mridula Kayal. "Neuroacanthocytosis: Presenting With Depression." Journal of Neuropsychiatry and Clinical Neurosciences 18, no. 3 (July 2006): 426. http://dx.doi.org/10.1176/jnp.2006.18.3.426.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Temprano-Fernández, M. T., J. M. Asensi-Álvarez, M. V. Álvarez-Martínez, and C. Buesa-García. "Neuroacanthocytosis: A new mutation." Neurología (English Edition) 32, no. 3 (April 2017): 197–99. http://dx.doi.org/10.1016/j.nrleng.2015.06.014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Surisetti, B. K., K. Neeraja, S. Prasad, V. Holla, N. Kamble, R. Yadav, and P. Pal. "Neuroacanthocytosis: Beyond movement disorders." Parkinsonism & Related Disorders 79 (October 2020): e108. http://dx.doi.org/10.1016/j.parkreldis.2020.06.391.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Danek, A., B. Bader, and R. H. Walker. "Antisocial behaviour and neuroacanthocytosis." International Journal of Clinical Practice 61, no. 8 (July 10, 2007): 1419. http://dx.doi.org/10.1111/j.1742-1241.2007.01371.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

Kazis, Aristidis, Vasilios Kimiskidis, Georgios Georgiadis, and Ekaterini Voloudaki. "Neuroacanthocytosis presenting with epilepsy." Journal of Neurology 242, no. 6 (1995): 415–17. http://dx.doi.org/10.1007/bf00868399.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Hori, A., S. Kazukawa, I. Nakamura, and M. Endo. "Electroencephalographic findings in neuroacanthocytosis." Electroencephalography and Clinical Neurophysiology 61, no. 5 (November 1985): 342–48. http://dx.doi.org/10.1016/0013-4694(85)91024-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Sharma, C., K. Nath, M. Acharya, B. L. Kumawat, D. Khandelwal, and D. Jain. "Cerebellar atrophy in neuroacanthocytosis." Case Reports 2014, jun06 1 (June 6, 2014): bcr2014205232. http://dx.doi.org/10.1136/bcr-2014-205232.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Bostantjopoulou, S., Z. Katsarou, A. Kazis, and C. Vadikolia. "Neuroacanthocytosis presenting as Parkinsonism." Movement Disorders 15, no. 6 (November 2000): 1271–73. http://dx.doi.org/10.1002/1531-8257(200011)15:6<1271::aid-mds1037>3.0.co;2-t.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

de Yebenes, J. G., M. F. Brin, M. A. Mena, C. De Felipe, R. M. del Rio, E. Bazan, A. Martinez, et al. "Neurochemical findings in neuroacanthocytosis." Movement Disorders 3, no. 4 (1988): 300–312. http://dx.doi.org/10.1002/mds.870030404.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Sibon, Igor, Imad Ghorayeb, Pierre Arné, and François Tison. "Distressing belching and neuroacanthocytosis." Movement Disorders 19, no. 7 (March 17, 2004): 856–59. http://dx.doi.org/10.1002/mds.20091.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

Zhu, Hui, Xue-min Feng, Teng Zhao, and Jing-yao Liu. "Neuroacanthocytosis with unusual clinical features." Medicine 98, no. 2 (January 2019): e14050. http://dx.doi.org/10.1097/md.0000000000014050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

Bruneau, Marie-Andrée, Paul Lespérance, and Sylvain Chouinard. "Schizophrenia-Like Presentation of Neuroacanthocytosis." Journal of Neuropsychiatry and Clinical Neurosciences 15, no. 3 (August 2003): 378–80. http://dx.doi.org/10.1176/jnp.15.3.378.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

Reid, Marion E. "McLeod neuroacanthocytosis: Genotype and phenotype." Transfusion Medicine Reviews 16, no. 3 (July 2002): 268. http://dx.doi.org/10.1016/s0887-7963(02)80074-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

Walterfang, Mark, Andrew Evans, Jeffrey Chee Leong Looi, Hans H. Jung, Adrian Danek, Ruth H. Walker, and Dennis Velakoulis. "The neuropsychiatry of neuroacanthocytosis syndromes." Neuroscience & Biobehavioral Reviews 35, no. 5 (April 2011): 1275–83. http://dx.doi.org/10.1016/j.neubiorev.2011.01.001.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

Rinne, J. O., S. E. Daniel, F. Scaravilli, M. Pires, A. E. Harding, and C. D. Marsden. "The neuropathological features of neuroacanthocytosis." Movement Disorders 9, no. 3 (1994): 297–304. http://dx.doi.org/10.1002/mds.870090303.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

Danek, Adrian, Justin P. Rubio, Luca Rampoldi, Mengfatt Ho, Carol Dobson-Stone, Fran�ois Tison, William A. Symmans, et al. "McLeod neuroacanthocytosis: Genotype and phenotype." Annals of Neurology 50, no. 6 (December 2001): 755–64. http://dx.doi.org/10.1002/ana.10035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

Okamoto, Kouichirou, Jusuke Ito, Tetsuya Furusawa, Kunio Sakai, Susumu Tokiguchi, Atsushi Homma, Ryoko Koike, and Shoji Tsuji. "CT and MR Findings of Neuroacanthocytosis." Journal of Computer Assisted Tomography 21, no. 2 (March 1997): 221. http://dx.doi.org/10.1097/00004728-199703000-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

Hadzsiev, Kinga, Mónika Szőts, Anett Fekete, László Balikó, Kim Boycott, Ferenc Nagy, and Béla Melegh. "Neuroacanthocytosis diagnózisa új generációs exom-szekvenálással." Orvosi Hetilap 158, no. 42 (October 2017): 1681–84. http://dx.doi.org/10.1556/650.2017.30880.

Full text

Abstract:

Abstract: In a patient with marked symptoms of Huntington disease after the huntingtin testing, which gave normal result, a whole exome sequencing (WES) has been performed based on an international collaboration. A homozygous G>A nucleotid change in the exon 34 of the VPS13A gene has been detected with WES, a mutation resulting in a premature stop codon at the position 1301. This change is a known pathogenic mutation. The aim of this article is to draw attention on the importance of the WES in the diagnosis of rare neurological diseases without any specific symptoms. Orv Hetil. 2017; 158(42): 1681–1684.

APA, Harvard, Vancouver, ISO, and other styles

32

Dubinsky, R. M., M. Hallett, R. Levey, and G. D. Chiro. "Regional brain glucose metabolism in neuroacanthocytosis." Neurology 39, no. 9 (September 1, 1989): 1253. http://dx.doi.org/10.1212/wnl.39.9.1253.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Tschopp, Lorena, Gabriela Raina, Zulema Salazar, and Federico Micheli. "Neuroacanthocytosis and carbamazepine responsive paroxysmal dyskinesias." Parkinsonism & Related Disorders 14, no. 5 (July 2008): 440–42. http://dx.doi.org/10.1016/j.parkreldis.2007.10.006.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Shang, H. "3.9.3 HUNTINGTON'S DISEASE AND NEUROACANTHOCYTOSIS SYNDROMES." Parkinsonism & Related Disorders 18 (January 2012): S165. http://dx.doi.org/10.1016/s1353-8020(11)70716-7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Bouguila, Hajer, Rafik Machraoui, Betbout Imen, and Younes Samia. "Neuroacanthocytose : à propos de trois cas." Revue Neurologique 176 (September 2020): S101. http://dx.doi.org/10.1016/j.neurol.2020.01.288.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Abdelmajid, Y., N. Altalai, and M. Atnasous. "Neuroacanthocytosis, a rare and challenging diagnosis." Journal of the Neurological Sciences 405 (October 2019): 230. http://dx.doi.org/10.1016/j.jns.2019.10.1235.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Kontoleon, P. E., I. Ilias, A. Matsouka, S. Gatzonis, C. Spiropoulou, and P. D. Papapetrou. "Impaired hypothalamic endocrine function in neuroacanthocytosis." Journal of Clinical Neuroscience 10, no. 6 (November 2003): 701–3. http://dx.doi.org/10.1016/s0967-5868(03)00166-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Delecluse, F., J. Deleval, J. M. Gerard, A. Michotte, and D. Z. de Beyl. "Frontal Impairment and Hypoperfusion in Neuroacanthocytosis." Archives of Neurology 48, no. 2 (February 1, 1991): 232–34. http://dx.doi.org/10.1001/archneur.1991.00530140130031.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Gültekin, Murat. "Clinical spectrum in neuroacanthocytosis: Two case reports." Journal of Parkinson’s Disease and Movement Disorders 22, no. 1-2 (March 16, 2020): 13–18. http://dx.doi.org/10.5606/phhb.dergisi.2019.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Kushwaha, Suman, Akhila Panda, Vachan Mehta, Seema Malik, and Ishita Pant. "Feeding dystonia: A classical presentation of neuroacanthocytosis." International Journal of Case Reports and Images 4, no. 1 (2013): 37. http://dx.doi.org/10.5348/ijcri-2013-01-255-cr-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

Zagidullina, K. L., and N. A. Popova. "Acute debut of neuroacanthocytosis in clinical practice." Kazan medical journal 97, no. 6 (December 15, 2016): 971–73. http://dx.doi.org/10.17750/kmj2016-971.

Full text

Abstract:

Neuroacanthocytosis is a rare autosomal dominant disease, which in its clinical manifestation is characterized by choreiform hyperkinesis, mental and cognitive disorders, signs of polyneuropathy and cardiomyopathy, and the basis of the disease is presence of modified erythrocytes (acanthocytes) in peripheral blood. The disease is characterized by autosomal dominant type of inheritance (the gene was mapped on chromosome 9q21), sporadic cases are possible. Description of a clinical case of a 63-year old patient with neuroacanthocytosis delivered by an ambulance with a preliminary diagnosis of stroke is provided. The patient complained of severe general fatigue, whole body shivering, and involuntary compulsive uncontrollable movements in the limbs, body, and face. The patient noted changes in her voice, probably due to compulsive movements of her tongue, lightheadedness, and shaky walk. Almost all physical and laboratory findings were within normal. Taking into account acuteness of the disease, its attack at the time of hypertensive emergency and patient’s age, circular cause was suggested, computed tomography of the brain and magnetic resonance imaging were performed. The results of neuroimaging ruled out the pathology of cerebral circulation. Ultrasound of neck vessels revealed nothing abnormal. Purposeful repeated blood analysis revealed that 85% of erythrocytes were acanthocytes and after that the correct diagnosis was made. The peculiarities of this clinical case are acute manifestation of symptoms and relatively late debut of the disease.

APA, Harvard, Vancouver, ISO, and other styles

42

Azman, Filiz, Murat Cabalar, Nejla Sozer Topcular, Arsida Bajrami, and Vildan Yayla. "A Case of Neuroacanthocytosis with Cerebellar Syndrome." Istanbul Medical Journal 16, no. 3 (October 8, 2015): 127–29. http://dx.doi.org/10.5152/imj.2015.76598.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Danek, A. "2.3.4 NEUROACANTHOCYTOSIS SYNDROMES AND OTHER HD-PHENOCOPIES." Parkinsonism & Related Disorders 18 (January 2012): S83. http://dx.doi.org/10.1016/s1353-8020(11)70398-4.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Witte, Thomas N., Adrian Danek, Michael Reiter, Marcell U. Heim, Josef Dirschinger, and Eckardt G. J. Olsen. "McLeod syndrome: a distinct form of neuroacanthocytosis." Journal of Neurology 239, no. 6 (1992): 302–6. http://dx.doi.org/10.1007/bf00867584.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Ghariani Fetoui, N., A. Aounallah, L. Boussofara, M. Gharmoul, R. Mesfar, A. Hassine, M. Ben Kahla, et al. "Automorsure et neuroacanthocytose : A propos d’un cas." La Revue de Médecine Interne 40 (June 2019): A208—A209. http://dx.doi.org/10.1016/j.revmed.2019.03.300.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Trujillo, O., L. Lay-Son, O. Loureiro, J. San Martin Varela, P. Lillo, and D. Saez. "Mc Leod neuroacanthocytosis syndrome: a case report." Journal of the Neurological Sciences 357 (October 2015): e291. http://dx.doi.org/10.1016/j.jns.2015.08.1013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Nabli, N., A. Aounallah, N. Ghariani Fetoui, S. Idoudi, R. Gammoudi, S. Mokni, M. Belkahla, C. Belajouza, L. Boussofara, and M. Denguezli. "La neuroacanthocytose: une cause de chéilite chronique." Annales de Dermatologie et de Vénéréologie 146, no. 12 (December 2019): A292. http://dx.doi.org/10.1016/j.annder.2019.09.479.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Sakai, T., H. Iwashita, and M. Kakugawa. "Neuroacanthocytosis syndrome and choreoacanthocytosis (Levine-Critchley syndrome)." Neurology 35, no. 11 (November 1, 1985): 1679. http://dx.doi.org/10.1212/wnl.35.11.1679.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Jankovic, J., J. M. Killian, and M. C. Spitz. "Neuroacanthocytosis syndrome and choreoacanthocytosis (Levine-Critchley syndrome)." Neurology 35, no. 11 (November 1, 1985): 1679. http://dx.doi.org/10.1212/wnl.35.11.1679-a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Lakhan, Shaheen E., and Kenneth Gross. "Progressive neuroacanthocytosis in brothers: a case report." Clinics 62, no. 5 (2007): 665–68. http://dx.doi.org/10.1590/s1807-59322007000500025.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!